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Abstract
Background: Hyperglycaemia during hospital admission is common in patients who are not known to have diabetes and is
associated with adverse outcomes. The risk of subsequently developing type 2 diabetes, however, is not known. We linked
a national database of hospital admissions with a national register of diabetes to describe the association between
admission glucose and the risk of subsequently developing type 2 diabetes.
Methods and Findings: In a retrospective cohort study, patients aged 30 years or older with an emergency admission to
hospital between 2004 and 2008 were included. Prevalent and incident diabetes were identified through the Scottish Care
Information (SCI)-Diabetes Collaboration national registry. Patients diagnosed prior to or up to 30 days after hospitalisation
were defined as prevalent diabetes and were excluded. The predicted risk of developing incident type 2 diabetes during
the 3 years following hospital discharge by admission glucose, age, and sex was obtained from logistic regression models.
We performed separate analyses for patients aged 40 and older, and patients aged 30 to 39 years. Glucose was measured
in 86,634 (71.0%) patients aged 40 and older on admission to hospital. The 3-year risk of developing type 2 diabetes was
2.3% (1,952/86,512) overall, was ,1% for a glucose #5 mmol/l, and increased to approximately 15% at 15 mmol/l. The risks
at 7 mmol/l and 11.1 mmol/l were 2.6% (95% CI 2.5–2.7) and 9.9% (95% CI 9.2–10.6), respectively, with one in four (21,828/
86,512) and one in 40 (1,798/86,512) patients having glucose levels above each of these cut-points. For patients aged 30–39,
the risks at 7 mmol/l and 11.1 mmol/l were 1.0% (95% CI 0.8–1.3) and 7.8% (95% CI 5.7–10.7), respectively, with one in eight
(1,588/11,875) and one in 100 (120/11,875) having glucose levels above each of these cut-points. The risk of diabetes was
also associated with age, sex, and socio-economic deprivation, but not with specialty (medical versus surgical), raised white
cell count, or co-morbidity. Similar results were obtained for pre-specified sub-groups admitted with myocardial infarction,
chronic obstructive pulmonary disease, and stroke. There were 25,193 deaths (85.8 per 1,000 person-years) over 297,122
person-years, of which 2,406 (8.1 per 1,000 person-years) were attributed to vascular disease. Patients with glucose levels of
11.1 to 15 mmol/l and .15 mmol/l had higher mortality than patients with a glucose of ,6.1 mmol/l (hazard ratio 1.54;
95% CI 1.42–1.68 and 2.50; 95% CI 2.14–2.95, respectively) in models adjusting for age and sex. Limitations of our study
include that we did not have data on ethnicity or body mass index, which may have improved prediction and the results
have not been validated in non-white populations or populations outside of Scotland.
Conclusion: Plasma glucose measured during an emergency hospital admission predicts subsequent risk of developing
type 2 diabetes. Mortality was also 1.5-fold higher in patients with elevated glucose levels. Our findings can be used to
inform patients of their long-term risk of type 2 diabetes, and to target lifestyle advice to those patients at highest risk.
Please see later in the article for the Editors’ Summary.
Citation: McAllister DA, Hughes KA, Lone N, Mills NL, Sattar N, et al. (2014) Stress Hyperglycaemia in Hospitalised Patients and Their 3-Year Risk of Diabetes: A
Scottish Retrospective Cohort Study. PLoS Med 11(8): e1001708. doi:10.1371/journal.pmed.1001708
Academic Editor: Derek Bell, Imperial College London, United Kingdom
Received March 4, 2014; Accepted July 17, 2014; Published August 19, 2014
Copyright:  2014 McAllister et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The authors confirm that, for approved reasons, some access restrictions apply to the data underlying the findings. The authors hold these
data under strict agreements with NHS Information Services Division Privacy Advisory Committee (PAC) and NHS Caldicott Officers (Caldicott) from the relevant
Health Boards. These agreements cover which analyses may be performed, how long the data may be held, and what level of data may be disclosed (only
aggregated non-identifiable summaries may be published). Details of the application process can be found on the NHS Information Services Division Electronic
Data Research and Innovation Service (eDRIS) website (http://www.isdscotland.org/Products-and-Services/EDRIS/). The authors are happy to support interested
parties who wish to access the data by sharing details of our approvals and by supporting and commenting on any applications to PAC and/or Caldicott for
access to data. In order to facilitate repetition of our analysis, we have also deposited the code we used to clean and merge the routine data in Edinburgh
University Data Repository (http://datashare.is.ed.ac.uk/).
PLOS Medicine | www.plosmedicine.org 1 August 2014 | Volume 11 | Issue 8 | e1001708
Funding: This work was supported by a research grant from the Chief Scientist Office for Scotland (CZH/4/836). NM is funded via an Intermediate Fellowship from the
British Heart Foundation. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
Abbreviations: COPD, chronic obstructive pulmonary disease; csHR, cause-specific hazard ratio; HR, hazard ratio; ICU, intensive care unit; MI, myocardial infarction;
OR, odds ratio; SCI-DC, Scottish Care Information-Diabetes Collaboration; sdHR, sub-distributional hazard ratio; SIMD, Scottish Index of Multiple Deprivation.
* Email: david.mcallister@ed.ac.uk
Introduction
Hyperglycaemia detected during acute illness is associated
with adverse outcomes. Among patients without known
diabetes admitted to hospital with myocardial infarction (MI),
stroke, pneumonia, and exacerbation of chronic obstructive
pulmonary disease (COPD), higher glucose levels are associated
with in-hospital and longer-term mortality, intensive care unit
admission, prolonged length of stay, and discharge to long-term
nursing care [1–8].
Hyperglycaemia during acute illness may be caused by drugs
such as systemic corticosteroids, thiazides, phenytoin, phenothia-
zines, protease-inhibitors, and beta-agonists [9–11] or as a result of
‘‘stress hyperglycaemia’’ where counter-regulatory hormones such
as glucagon, cortisol, catecholamines, and growth hormone
promote hepatic gluconeogenesis [12]. Hyperglycaemia detected
during acute illness may also be the first clinical evidence of
underlying or incipient type 2 diabetes.
In gestational diabetes, an analogous condition wherein
hyperglycaemia detected during pregnancy can either be due to
pre-existing undiagnosed diabetes or to physiological changes that
occur during pregnancy, the risk of persistent hyperglycaemia
resulting in a diagnosis of diabetes after delivery has been
established in large cohort studies [13]. The same is not true for
acute illness related hyperglycaemia, however, as follow-up studies
examining this question have generally been limited to specific
diseases (coronary disease [14–17], stroke [18,19], or pneumonia
[20]) and have generally been small, of short duration, and with
considerable loss to follow-up [21–28].
A number of scores allow clinicians to select which patients in
primary care have a sufficiently high risk of type 2 diabetes to
merit a blood glucose test, on the basis of demographic, lifestyle,
and anthropometric characteristics [29,30]. These scores, howev-
er, do not help clinicians faced with interpreting an abnormally
high result when glucose has already been measured as part of a
routine panel of blood tests following admission to hospital, and
where it is uncertain whether stress hyperglycaemia or type 2
diabetes is the underlying cause. Consequently, clinicians are
currently unable either to advise patients on the clinical
significance of raised glucose during acute illness, or to decide
what if any follow-up testing is appropriate.
Scottish Care Information (SCI)-Diabetes Collaboration (SCI-
DC) is a national register including over 99% of people with
diabetes in Scotland [31]. All emergency hospitalisations are
recorded on the national Scottish Morbidity Record (SMR01) and
all biochemistry and haematology laboratory measurements are
recorded in the SCI-Store databases in each Health Board.
Using these large representative routine data sources, we
describe the association between admission venous glucose level
and 3-year risk (cumulative incidence) of type 2 diabetes among
patients without known diabetes following an emergency admis-
sion to hospital. Similarly, as an additional outcome, we examined
the association between admission glucose and mortality.
Methods
Ethics Statement
We obtained advice from the Research Ethics Committee
(available from the author on request) that the research did not
require ethical approval as this was a secondary analysis of routine
anonymised data. Access to data for the purpose of performing this
research was approved by NHS Information Services Division
Privacy Advisory Committee (Ref 63/12) and the Caldicott
Officer of each NHS Health Board in Scotland (via the Scotland-
wide approval scheme).
Patients
Using a unique identifier we performed a novel linkage of data
on hospital admissions from the Scottish Morbidity Record
(SMR01), laboratory results from SCI-Store, and diagnosis of
diabetes from SCI-DC for three large Scottish Health Boards (Fife,
Greater Glasgow and Clyde, and Lothian). Together these three
Health Boards provide health care to approximately 2.4 million
people, 46% of the Scottish population (General Registrar Office
Scotland).
All patients aged 30 years or older who required emergency
hospitalisation to internal medicine or surgical specialties, and
were resident in the Health Board area in which the hospital was
sited were included. We had originally planned only to examine
the risk of type 2 diabetes for patients aged 40 and older as type 2
diabetes is rare in patients below this age. At the review stage,
however, it was noted that our cohort presents an opportunity to
examine associations among younger patients, who, in the absence
of risk factors such as family history, are not normally offered
testing for type 2 diabetes, and so we extended the analyses to
include the younger age group [32,33]. As this analysis was
suggested during peer review, and was not part of our original
protocol, results for younger patients aged 30 to 39 are reported
separately. The introduction of standardised recording and coding
of blood results was introduced across Scotland gradually.
Therefore, the start of the inclusion period varied from December
2004 to March 2008 according to the admitting hospital. Data
were extracted from SCI-DC on 1st December 2011, and
therefore to ensure a minimum of 3-years follow-up for all
patients we included patients admitted up to the 31st of November
2008. Where a patient had more than one admission during the
study period the first was selected.
Prevalent diabetes was defined in patients with type 1 or type 2
diabetes diagnosed prior to the index admission or within 30 days
of discharge, as recorded in SCI-DC. Patients with prevalent
diabetes were excluded, as were those who died prior to discharge
from hospital.
Having already completed our data analysis we unexpectedly
were able to obtain data for an additional Scottish Health Board,
NHS Tayside, which has a population of approximately 300,000.
Hence, we used these additional data as a validation cohort.
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Outcomes
Incident type 2 diabetes was defined as having type 2 diabetes
recorded on SCI-DC between 31 days and 3 years after the date of
discharge from hospital. This definition was chosen to ensure that
those patients who were admitted to hospital with a new diagnosis
of diabetes, but in whom the diagnosis was not confirmed until a
subsequent visit to primary care or an out-patient clinic, were not
designated as incident cases. We chose 3 years as we felt that this
was a reasonable compromise between selecting a timescale that
was relevant for clinical decision making, while also allowing
detection of most incipient cases of diabetes.
SCI-DC is a real-time single electronic record that is used to
deliver and document all diabetes-related health care in Scotland.
Clinical and administrative data are recorded for all diabetes care
occurring in primary and secondary care (including physician,
podiatry, dietetics, laboratory, and retinopathy services) for all
adults and children with diabetes. SCI-DC is implemented across
all NHS regional (Health Boards) within Scotland, and includes
99% of people resident in Scotland diagnosed with diabetes [31].
We also obtained outcome data on mortality from National
Records Scotland (formerly General Registrar Office Scotland),
which includes deaths occurring outside Scotland but within the
UK. Deaths were defined as vascular if the underlying cause of
death from the death certificate was coded, according to the tenth
revision of International Classification of Diseases (ICD-10), as
ischaemic heart disease (I20–I25), stroke (I63, I64, and I67), or
other vascular diseases (I70–I79). Deaths were otherwise defined as
non-vascular.
Exposure
The first glucose measurement within 2 days of admission was
defined as the admission glucose. A very small number of patients
without prevalent diabetes (n= 122) had an admission glucose of
.20 mmol/l and were excluded from all further analyses as these
patients were assumed to have prevalent diabetes not recorded in
the SCI-DC database owing to error.
Covariates
Data on age, sex, and quintiles of the 2009 version of the
Scottish Index of Multiple Deprivation (SIMD, an area-based
measure of socio-economic deprivation) was obtained from the
SMR01 database of hospitalisations. Specific diseases were defined
if the primary cause of admission was coded (using ICD-10) as MI
(I20–I25), stroke (G45 and I60–I67), COPD (J40–J44), or fracture
(S02, S12, S22, S32, S42, S52, S62, S72, S82, and S92). The
Charlson Index was calculated using the primary diagnosis
recorded on SMR01 for all admissions during the five years prior
to the index admission. Raised white cell count defined as $
116109/l was included as a marker of acute stress.
Statistical Analyses
Summary statistics for baseline characteristics were compared
by category of admission glucose. As described in our pre-stated
analysis plan (Protocol S1), we present the risk of diabetes across
the range of glucose levels, which is a continuous measurement.
Nevertheless, for illustration, cut-points for admission glucose were
also chosen on the basis of the WHO criteria for defining
categories of glucose tolerance, with an additional cut-off to
indicate very high glucose: ,6.1, 6.1–6.9, 7.0–11.0, 11.1–14.9,
and $15 mmol/l for fasting/non-fasting samples [34].
The odds of type 2 diabetes within 3 years from discharge was
modelled using logistic regression. Glucose was log-transformed
for all regression analyses as a linearizing transformation. A priori
we expected non-linear associations and so included polynomial
terms in all models. We had originally planned to use non-
parametric smoothers to allow for non-linearity, but used
polynomials instead as these allow easier calculation of predicted
values. The predicted 3-year risk of type 2 diabetes by level of
admission glucose and covariates was obtained from these models.
Discrimination was calculated as the area under the receiver
operator characteristic curve (C-Statistic) with confidence intervals
obtained via bootstrapping for both the development and
validation cohorts using coefficients obtained from the model
derived from the development cohort.
Interaction terms were used to examine whether associations
differed for pre-specified sub-groups (admissions to medical versus
surgical admissions, admission to intensive care units [ICUs], and
admissions with principal diagnoses of MI, stroke, COPD, and
fracture) and raised white cell count (as a marker of acute stress).
In sensitivity analyses we repeated the analyses for the sub-
group of patients in whom there was 5 years of follow-up. In
additional exploratory analyses we plotted the cumulative
incidence of diabetes and death according to admission glucose
(via estimating the sub-distribution cumulative incidence function
for each stratum) using the entire follow-up time available for each
patient, which ranged from 3 to 6.9 years. For this follow-up
period, we examined associations between mortality and admis-
sion glucose using Cox proportional hazards models. We also
modelled the cause-specific hazard ratio (csHR) for incident type 2
diabetes using Cox proportional hazard models, treating all-cause
death as a censoring event, and modelled the sub-distributional
hazard ratios (sdHRs) of type 2 diabetes using Fine and Gray
models [35] (the most widely used method for modelling
competing risks for time to event data) treating death as a
competing risk.
All analyses were performed in R version 3.0.1 (R Project for
Statistical Computing). Cox regression models and Fine and Gray
models were fit using the survival and cmprsk packages,
respectively [36,37].
Systematic Review
We completed a brief systematic review addressing the research
question ‘‘What is the risk of type 2 diabetes according to
admission glucose in acutely unwell hospitalised patients?’’ The
search was performed on the 14th of October 2013. Table S1
reports the search terms. We included studies published in English
on or after January 2000 for adults who had a non-elective hospital
admission in whom diabetes status was assessed following
discharge from hospital, and where the risk of type 2 diabetes
was reported according to glucose level within 48 hours of
admission. Studies that only reported the admission glycaemic
status defined on the basis of an oral glucose tolerance test
(OGTT) were excluded. We did not exclude studies that only
reported fasting and not random admission glucose. Details of
each study were tabulated. No meta-analysis was performed.
Results
Baseline Characteristics
A total of 141,831 patients aged 40 and older met the inclusion
criteria. Of these, 1,141 (0.8%) died during admission and 18,689
(13.2%) had prevalent diabetes and so were excluded. A total of
86,634 (71.0%) of the remaining 122,001 had a glucose measure
within 2 days of admission (Figure 1).
Patients admitted to medical specialties were more likely to have
glucose measured than those admitted to surgical specialties
(62,508 [80.8%] versus 28,356 [56.9%]) as were those with MI,
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stroke, and COPD (89.9%, 89.6%, and 86.0%, respectively), and
those older than 80. Glucose measurement was not, however,
related to sex or socio-economic deprivation (Table 1). The 3-year
risk of diabetes was similar in patients with and without glucose
measured on admission (2.3% [1,965/84,669] versus 2.0% [725/
34,642]).
Patients with glucose measures were on average 66.3 years old
and 40,596 (46.9%) were male. As expected for a hospitalised
population, people resident in more socio-economically deprived
areas were overrepresented (Table 2).
Distribution of Glucose
Admission glucose was ,6.1 mmol/l for 53.7% (46,499/
86,512) of patients, and was between 6.1 and 6.9 mmol/l for
21.0% (18,185/86,512), $7 mmol/l for 25.3% (21,828/86,512),
and $11.1 mmol/l for 2.1% (1,798/86,512) of patients. For
patients with MI, COPD, and fracture the percentage with glucose
$7 mmol/l was approximately 5% higher than for patients overall
(30.8% [1,916/6,204], 30.4% [917/3012], and 31.1% [1,572/
5,057], respectively).
Patients with higher glucose levels were on average older and
were more likely to have been admitted to an ICU than those with
lower levels. Co-morbidity (assessed via Charlson Index) and a
raised white cell count was also more common in patients with
elevated glucose (Table 2).
3-Year Risk of Type 2 Diabetes
The 3-year risk of type 2 diabetes was 2.3% (1,952 of 86,512). The
3-year risk, by category of glucose, age, and sex is presented in Table 3.
In logistic regression models, the 3-year risk of type 2 diabetes
was strongly associated with admission glucose (Figure 2). From a
very low risk of diabetes with glucose levels ,5 mmol/l the risk
increased linearly to 15 mmol/l before reaching a plateau. The 3-
year risks of diabetes at the WHO cut-points for diagnosing
diabetes on fasting (7 mmol/l) and random (11.1 mmol/l) samples
were 2.6% (95% CI 2.5–2.7) and 9.9% (95% CI 9.2–10.6),
respectively, with a risk of 5.7% at 9 mmol/l.
At every level of glucose, the 3-year risk of diabetes was higher
in men than women. The association with age was non-linear
(Figure 3), with the highest risk of diabetes among patients aged 50
to 69 with lower risks for both younger and older patients. The risk
was particularly low for those over 80 years of age. Socio-
economic deprivation was strongly associated with an increased
risk of diabetes (odds ratio for least deprived versus most deprived
Figure 1. CONSORT style flowchart of patients included in analysis.
* This group of 86,634 patients includes the n= 122 whose glucose was .20 mmol/l and so were assumed to have prevalent diabetes.
doi:10.1371/journal.pmed.1001708.g001
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quintile 0.74; 95% CI 0.64–0.85) (Table 4). There was no
statistically significant evidence of interaction with glucose on a
multiplicative scale for age, sex, or SIMD: the odds ratio (OR) for
interaction was 0.94 (95% CI 0.86–1.02, p= 0.13) per ten years of
age, 1.11 (95% CI 0.90–1.36, p= 0.33) for sex, and 1.00 (95% CI
0.94–1.08, p= 0.89) per 1 quintile increment in SIMD.
In models adjusting for age, sex, and admission glucose, neither
speciality (medical OR 1.09; 95% CI 0.98–1.21, p= 0.10),
elevated white cell count (OR 0.93; 95% CI 0.80–1.08, p= 0.31)
nor co-morbidity (Charlson Index greater than zero, OR 1.04;
95% CI (0.94–1.14), p= 0.48) were associated with 3-year risk of
diabetes. Nor was there statistically significant evidence of
interaction on a multiplicative scale between these variables and
admission glucose: the OR for interaction was 0.85 (95% CI 0.67–
1.06, p= 0.16) for medical specialty, 0.83 (95% CI 0.58–1.13,
p= 0.27) for elevated white cell count, and 0.89 (95% CI 0.73–
1.10, p= 0.29) for Charlson Index greater than zero.
Sub-group Analyses
Associations for each sub-group, examined via adding interac-
tion terms with glucose, are shown in Figure 4. The overall risk of
diabetes for patients admitted to ICU was lower than the general
population, and the association between hyperglycaemia and risk
of type 2 diabetes was weaker in both absolute and relative terms
(Table 5). The risks were similar for surgical and medical
specialties, however, and for each of the groups defined by pre-
specified diagnoses (Figure 4). Similar results were obtained in
stratified analyses (Figure S1).
Prediction
Discrimination for admission glucose in predicting 3-year risk of
diabetes in the development cohort was good. For age, sex, and
glucose the area under the receiver operator characteristic curve
(C-statistic) was 0.75 (95% CI 0.74–0.76), which was an
improvement over the C-statistic for age and sex alone which
was 0.62 (95% CI 0.61–0.64).
The independent validation cohort comprised the 22,655
patients with an emergency medical or surgical hospital admission
to Ninewells hospital in NHS Tayside from 2005 to 2008.
Laboratory data were provided for this cohort by the Health
Informatics Centre, University of Dundee. The patient character-
istics were similar to that of the development cohort (Table 2). In
this cohort the C-statistic for glucose, age, and sex was 0.75 (95% CI
0.73–0.76), so there was no evidence of over-fitting (Figure 5).
Mortality
Follow-up time for the entire cohort of 86,512 patients aged 40
and older comprised 297,122 person-years (median 3.6, inter-
quartile range 2.7–4.7, and maximum 6.9 person-years) during
which there were 2,724 cases of incident diabetes (9.2 per 1,000
person-years) and 25,193 deaths (85.8 per 1,000 person-years), of
which 2,406 (8.1 per 1,000 person-years) were due to vascular
disease.
Admission glucose was associated with increased mortality rates
as well as with increased risk of type 2 diabetes. The mortality rate
was 7.48 per 100 person-years (12,315/164,548) for patients with
a glucose level ,6.1 mmol/l compared to 13.9 (603/4,337) for
Table 1. Glucose measurement on admission by patient characteristics.
Variable Value Number (%)a
Total 86,634 (71.0)
Age (years) 40 to 49 15,786 (70.2)
50 to 59 15,324 (70.4)
60 to 69 16,107 (68.5)
70 to 79 18,989 (69.6)
.80 20,428 (75.8)
Sex Women 45,972 (69.6)
Men 40,662 (72.7)
SIMD Quintile 1 (most deprived) 25,012 (71.5)
Quintile 2 18,812 (71.9)
Quintile 3 13,221 (71.2)
Quintile 4 12,106 (70.1)
Quintile 5 (least deprived) 17,483 (69.9)
Specialty Medicine 62,508 (80.8)
Surgery 28,356 (56.9)
ICU 1,853 (81.8)
Diagnostic sub-groups MI 6,215 (89.9)
Stroke 3,753 (89.6)
COPD 3,016 (86)
Fracture 5,061 (63.9)
Hospital 68.5 (64.5–74.1) [22.6]
aAll figures are counts (%) except for hospital, for which the proportion with glucose measures across hospitals was summarised using the median (interquartile range)
and [range].
doi:10.1371/journal.pmed.1001708.t001
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patients with a glucose level of 11.1–14.9 mmol/l (Table 6).
However, the association was considerably stronger for diabetes
(Figure 6). Patients with glucose levels of 11.1–15 mmol/l and .
15 mmol/l had higher mortality than patients with a glucose of ,
6.1 mmol/l (hazard ratio [HR] 1.54; 95% CI 1.42–1.68 and 2.50;
95% CI 2.14–2.95, respectively) in models adjusting for age and
sex. Stronger associations were found for deaths due to vascular
disease than for other causes of death. For example, compared to
patients with glucose ,6.1 mmol/l those with glucose in the 11.1–
14.9 mmol/l range had higher vascular (HR 2.61; 95% CI 2.12–
3.20) than non-vascular mortality rates (HR 1.34; 95% CI 1.22–
1.46). Table 6 presents mortality results for glucose modelled both
as a categorical and a continuous variable, for both unadjusted
and adjusted models.
Table 3. 3-year risk of type 2 diabetes stratified by admission glucose, age, and sex.
Sex Age (y)/Glucose (mmol/l) ,6.1 6.1–6.9 7.0–11.0 11.1–14.9 $15
Men 30–39 10 (0.3) 10 (1.0) 22 (2.7) 4 (6.5) 4 (30.8)
40–69 198 (1.4) 154 (3.1) 321 (6.2) 77 (18.5) 24 (27.6)
70–79 52 (1.2) 39 (1.9) 109 (4.7) 35 (18.3) 5 (12.5)
80 and older 17 (0.5) 9 (0.6) 33 (1.8) 9 (6.7) 1 (4)
Women 30–39 12 (0.3) 3 (0.4) 13 (2.1) 3 (8.3) 3 (33.3)
40–69 133 (1) 86 (2.1) 206 (5.1) 52 (18.9) 13 (18.3)
70–79 54 (1.1) 47 (2) 113 (4.1) 18 (9.8) 4 (9.5)
80 and older 21 (0.3) 24 (0.8) 77 (2.0) 19 (6.8) 2 (3.8)
All data are n (%).
doi:10.1371/journal.pmed.1001708.t003
Figure 2. 3-year risk of type 2 diabetes by admission glucose. The solid line represents the estimate and the ribbon represents the 95% CI
obtained from a logistic regression model of incident type 2 diabetes on glucose, glucose-squared, and glucose-cubed. Points represent the risk of
diabetes for patients categorised according to admission glucose, with the x-axis indicating the mean glucose level and the point size indicating the
number of patients for each category.
doi:10.1371/journal.pmed.1001708.g002
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Competing Risks
In exploratory time to event analyses, death did not appear to
be an important competing risk in terms of the association
between admission glucose and diabetes. Over 297,122 person-
years of follow-up (median 3.6, interquartile range 2.7–4.7, and
maximum 6.9 person-years) there were 25,193 deaths and 2,724
cases of incident diabetes. The csHR (where death is treated as a
censoring event) and the sdHR (where death is treated as a
competing event) were similar: for example the csHR and sdHR
for patients with a glucose of 11.1–14.9 mmol/l (compared to a
glucose of ,6.1 mmol/l) were 14.1 and 12.0, respectively
(Table 7). Figure 7 presents the predicted risks based on the
csHRs and sdHRs across the range of glucose levels. For glucose
levels ,15 mmol/l, the risk of diabetes was very similar for both
models. For glucose levels $15 mmol/l the risks estimated from
the csHRs were higher than those from the sdHRs. Nevertheless,
both models resulted in predicted 3-year risks of diabetes above
18% for glucose levels $15 mmol/l.
Very similar results were found in the sub-group of patients who
had been admitted to ICU (Table S2).
Death did not appear to be a competing risk in terms of the
association between age and diabetes either. Indeed, the sdHR for
age and age-squared was higher than the csHR (Table 8).
Younger Patients
In a post hoc analysis requested during the peer review process,
we examined associations for patients aged 30 to 39 years old. A
total of 18,643 patients in this age-group had an emergency
admission to hospital during the study period and met the
inclusion criteria. Of these, 13 (0.07%) died during admission and
658 (3.5%) had prevalent diabetes and so were excluded. A total of
11,889 (66.2%) of the remaining 17,972 had a glucose measure
within 2 days of admission. A total of 14 patients had a glucose of
.20 and were excluded from all further analyses.
Compared to patients aged $40 years, patients aged 30 to 39
years were more likely to have a high white cell count (35.0%
versus 31.7%), to be admitted to surgical specialties, and to reside
in an area with high deprivation than were older patients (Table
S3). COPD, MI, stroke, and comorbidity were very uncommon in
this group (all ,1%).
Admission glucose was above the conventional cut-points around
half as often in younger patients compared to older patients. Only
1,588 (13.1%) of younger patients had glucose $7 mmol/l and 120
(1%) of younger patients had glucose$11.1 mmol/l (Table S4). The
3-year risk of type 2 diabetes was 0.7% (84/11,875) overall.
In logistic regression models, similar associations were observed
for admission glucose and 3-year risk of type 2 diabetes as were
seen among older patients (Table 9). Consistent with the lower
overall risk, the 3-year risks of diabetes at the WHO cut-points for
diagnosing diabetes on fasting (7 mmol/l) and random
(11.1 mmol/l) samples were low: 1.0% (95% CI 0.8–1.3) and
7.8% (95% CI 5.7–10.7), respectively, with a risk of 3.3% at
9 mmol/l.
Sensitivity Analyses
Of the 27,190 patients with five or more years of follow-up, 932
(3.4%) developed type 2 diabetes within 5 years. Across age and
sex strata the 5-year risk of type 2 diabetes according to admission
glucose level was similar to the 3-year risk (Figure 8).
Figure 3. 3-year risk of type 2 diabetes by admission glucose, age, and sex. The solid lines represent the estimates with ribbons indicating
95% CIs obtained from a logistic regression model of incident type 2 diabetes on glucose, glucose-squared, and glucose-cubed, adjusting for age and
sex.
doi:10.1371/journal.pmed.1001708.g003
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Systematic Review
From the 2,555 titles identified 2,514 irrelevant or duplicate
articles were excluded. On full-text review, 13 of the 41 remaining
articles met the selection criteria [14–20,23,24,27,38–40]. All but
two studies were single centre and the majority recruited only
patients with specific diseases, most commonly acute coronary
disease or stroke. Inclusion/exclusion criteria were heterogeneous
in terms of age and other risk factors, as were definitions of stress
hyperglycaemia and subsequent diabetes. Only five studies had
more than 12 weeks follow-up (range 2.5–5 years) and of these,
with the exception of one study that followed up more than 95% of
2,215 people with community acquired pneumonia [20], the
Table 4. 3-year risk of type 2 diabetes by glucose, age, sex, and Scottish Index of Multiple Deprivation (SIMD) score: coefficients
and odds ratios from logistic regression models.
Variable in Model Model 1 Model 2
Coefficient OR (95% CI) Coefficient OR (95% CI)
Intercept 213.052 213.052
Age, per ten years, squared 2.052 7.78 (5.50–11.00) 2.05 7.77 (5.49–10.98)
Age, per ten years, squared 20.176 0.84 (0.82–0.86) 20.175 0.84 (0.82–0.86)
Women 20.196 0.82 (0.75–0.90) 20.2 0.82 (0.75–0.90)
Glucose 22.375 0.09 (0.07–0.13) 22.356 0.09 (0.07–0.13)
Glucose squared 3.723 41.40 (24.65–69.50) 3.719 41.22 (24.53–69.27)
Glucose cubed 20.749 0.47 (0.41–0.54) 20.75 0.47 (0.41–0.54)
SIMD Quintile 1 (most deprived) — — 0.298 1.35 (1.17–1.55)
SIMD Quintile 2 — — 0.301 1.35 (1.17–1.57)
SIMD Quintile 3 — — 0.137 1.15 (0.97–1.35)
SIMD Quintile 4 — — 0.079 1.08 (0.91–1.29)
SIMD Quintile 5 (least deprived) — — 0 1
There were no statistically significant interactions (on the scale of the linear predictor) for any of these variables. The natural logarithm of glucose in mmol/l was used for
all models. Glucose provided in mg/dl should be converted to mmol/l by dividing by 18. The 3-year risk of type 2 diabetes is the inverse logit of the linear predictor (sum
of the relevant coefficients). For example, for a male patient aged 60 with a glucose of 5 mmol/l the risk of type 2 diabetes is calculated as follows:
log 5ð Þ~1:609
Linear:predictor~{13:052z2:052|6{0:176|36{0:196|0{2:375|1:609z3:723|1:6092{0:749|1:6093~{4:379
3-year risk~e{4:379

e{4:379z1
 
~1:2%:
Fitted values with standard errors and the model variance/covariance matrix are shown in Tables S8 and S9. We have also provided an online tool to carry out this
calculation, which is available at www.cphs.mvm.ed.ac.uk/diabetes-risk/.
doi:10.1371/journal.pmed.1001708.t004
Figure 4. 3-year risk of type 2 diabetes by glucose for patients in sub-groups. Predicted 3-year risks of type 2 diabetes by glucose level
obtained from logistic regression models. All models adjust for age, sex, and a main term and interaction term with glucose for the relevant grouping
variable (e.g., admission to ICU). Lines represent estimates and ribbons indicate 95% CIs with blue used to indicate membership of the relevant sub-
group and red used to describe the remainder of the population.
doi:10.1371/journal.pmed.1001708.g004
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completeness of follow-up was low. The resultant estimates for
subsequent risk of type 2 diabetes according to stress hypergly-
caemia therefore varied from 7% to 36%, and results were not
presented stratified by age and/or sex (Table S7).
Discussion
Admission glucose is measured routinely on emergency
hospitalisation, and is above the (symptomatic) cut-point for
diagnosis of diabetes (7.0 mmol/l) in over one-quarter of patients.
Clinicians are unclear as to the longer term significance of an
elevated glucose. Our study is the first, to our knowledge, to report
the long term risk of diabetes in this group of patients on a
population level. We report that the 3-year risk of type 2 diabetes
was ,1% for patients with a glucose of #5 mmol/l and increased
linearly to approximately 15% at 15 mmol/l, above which there
was no further increase in risk. The 3-year risks at the WHO
diabetes diagnostic cut-points for fasting (7 mmol/) and random
(11.1 mmol/l) glucose [34] were 3% and 10%, respectively. One
in four and one in 40 patients had a glucose level above these
respective cut-points. For the first time, to our knowledge, these
results will allow doctors to inform patients of their future risk of
diabetes and will direct future guidelines on the appropriate
follow-up of abnormal hospital glucose results.
Our findings confirm that single measures using the WHO cut-
points for diagnosing diabetes, which are not based upon studies
that measured glucose in the emergency setting [34], cannot be
directly applied in acutely unwell patients with hyperglycaemia.
Indeed, we found that 90% of patients with an admission glucose
of 11.1 mmol/l were not diagnosed with diabetes within 3 years of
discharge from hospital. This figure is likely to be lower in
populations with a higher baseline risk of diabetes, but even for
settings where the baseline risk of diabetes is 4-fold higher, we would
still expect fewer than half of patients with an admission glucose of
11.1 mmol/l to be diagnosed with diabetes within 3 years. As such,
for most countries and health care systems, clinicians treating
Table 5. Predicted 3-year risk of type 2 diabetes in patients admitted to ICU compared to patients not admitted to ICU.
Glucose mmol/l Not Admitted ICU Admitted ICU
Risk (95% CI) Risk Difference (Risk Ratio) Risk (95% CI) Risk Difference (Risk Ratio)
5 1.09 (0.95–1.24) reference 1.40 (0.72–2.71) reference
10 11.75 (10.62–12.97) 10.66 (10.77) 3.17 (1.98–5.02) 1.77 (2.26)
15 25.69 (22.34–29.36) 24.6 (23.57) 7.13 (4.11–12.10) 5.73 (5.09)
Estimates and 95% CIs were obtained from logistic regression models with ICU as an interaction term. The reference category for each risk ratio and risk difference was
the risk for patients with admission glucose equal to 5 mmol/l.
doi:10.1371/journal.pmed.1001708.t005
Figure 5. Receiver operator characteristic curve for development and validation cohorts. The ribbon represents the 95% CIs.
doi:10.1371/journal.pmed.1001708.g005
Stress Hyperglycaemia in Hospitalised Patients and Risk of Diabetes
PLOS Medicine | www.plosmedicine.org 10 August 2014 | Volume 11 | Issue 8 | e1001708
patients in whom a high glucose is detected during an emergency
hospital admission can be reassured that the most likely diagnosis is
stress hyperglycaemia rather than type 2 diabetes.
Consistent with previous reports, we also found that high
admission glucose was associated with increased mortality [1,2,4–
8], and that the association was stronger for deaths related to vascular
diseases compared to other causes of death. The association for
mortality was, however, 2-fold to 5-fold weaker than the association
for type 2 diabetes. This weaker association, in relative terms, may
partly explain why death did not appear to be a ‘‘competing risk’’ for
incident type 2 diabetes, that is increased deaths among patients with
high blood glucose levels, compared to those with lower blood glucose
levels, did not have an important impact on the relationship between
admission glucose and incidence of type 2 diabetes.
Nevertheless, there were around six more deaths per 100
person-years among patients with glucose levels above
11.1 mmol/l, compared to patients with glucose ,6.1 mmol/l,
which is a large absolute difference in mortality rate. Moreover,
the association with mortality was only slightly attenuated on
adjusting for age, sex, socio-economic deprivation, comorbidity,
COPD, and medical specialty. Consequently, patients with
hyperglycaemia can be considered to be at considerably higher
risk of both death and diabetes.
Previous follow-up studies have estimated the risk of type 2
diabetes among patients with hyperglycaemia [14–28]. In the best
of these, a case-series of 2,215 patients in Alberta, Canada with
community acquired pneumonia, the risk of type 2 diabetes was
increased in 473 patients with moderate hyperglycaemia (7.8–
11.0 mmol/l) and 104 patients with severe hyperglycaemia (11.1–
20.0 mmol/l), but was not higher for mild hyperglycaemia (6.1–
7.0 mmol/l) [20]. We found similar relative risks for moderate and
severe hyperglycaemia. However, in a representative sample of
more than 85,000 patients, in which approximately 2,000
developed incident diabetes over 3 years, we identified that the
Figure 6. Cumulative incidence of mortality and type 2 diabetes by admission glucose. Non-parametric estimates of cumulative incidence
of mortality and incident type 2 diabetes according to admission glucose. The ribbon represents the 95% CIs.
doi:10.1371/journal.pmed.1001708.g006
Stress Hyperglycaemia in Hospitalised Patients and Risk of Diabetes
PLOS Medicine | www.plosmedicine.org 11 August 2014 | Volume 11 | Issue 8 | e1001708
association between admission glucose and risk of type 2 diabetes
was linear in the 5–15 mmol/l range. Consequently even
mild hyperglycaemia is associated with increased risk of type 2
diabetes.
Our large sample size also allowed us to examine whether the
association between risk of diabetes and glucose level differed
according to age and sex. We found that men had a higher risk of
diabetes at every level of glucose, while patients aged 50–69 years
were at higher risk than both older and younger age groups.
We also examined diabetes risks according to admission glucose
for pre-specified admission diagnoses and found similar associations
to the main analyses for patients admitted with MI, COPD, stroke,
and fracture. Current guidance for the management of patients with
acute coronary syndrome suggest, on the basis of short-term follow-
up studies [21,22,25,26], that patients with hyperglycaemia without
diabetes should be screened for diabetes at least annually [41]. This
recommendation may be refined on the basis of the estimates of the
risk of diabetes that we have provided.
We have provided a risk calculator to allow clinicians to
estimate the age-sex specific 3-year risk of type 2 diabetes (Glucose
on Unselected Admissions and Risk of Diabetes [GUARD]: Type
2 Diabetes Risk Calculator available at www.cphs.mvm.ed.ac.uk/
diabetes-risk/). Since we obtained similar results for medical and
surgical specialities, across a number of common clinical
conditions, and for patients with and without comorbidity, this
tool is likely fairly robust to moderate differences in the
organisation of secondary care, and may therefore be used in
settings that have similar age-sex specific risks of diabetes to those
observed in Scotland [42].
Prediction scores have previously been developed to estimate
the risk of developing type 2 diabetes in order to identify healthy
people in whom glucose should be measured [29,30]. Instead, our
score was designed to aid clinicians faced with interpreting an
abnormally high glucose level discovered following a routine panel
of blood tests during admission to hospital, where it is uncertain
whether stress hyperglycaemia or type 2 diabetes is the underlying
cause. Nonetheless, the area under the curve we observed in our
validation cohort (C-statistic 0.75) was comparable to that of non-
biomarker based scores when externally validated in the Kora and
Whitehall cohorts (C-statistics ranged from 0.62 to 0.68 [29] and
0.61 to 0.67 [30], respectively).
There is on-going controversy concerning screening for type 2
diabetes in the general adult population and for specific-disease
groups, and professional and guideline bodies in different countries
differ in their recommendations on which adults should be
screened [32,43,44]. Notwithstanding these differences in care,
since patients with an admission glucose level of 11.1 mmol/l have
a 3-year risk of type 2 diabetes of 10% (5-fold higher than the risk
in the general population), we propose that patients whose
admission glucose is at or above this concentration should be
offered follow-up testing. Since fewer than one in 40 patients had a
glucose level$11.1 mmol/l, repeat testing should be achievable in
most health care settings.
For lower glucose levels, our findings will allow clinicians to
communicate to patients their risk of diabetes, and to provide
simple lifestyle modification advice as appropriate. Ultimately, we
hope that our findings will be incorporated into modelling studies
comparing the cost-effectiveness of different strategies for identi-
Table 6. Mortality according to admission glucose.
Patient Characteristics/Glucose (mmol/l) ,6.1 6.1–6.9 7.0–11.0 11.1–14.9 $15
N 46,499 18,185 20,030 1,480 318
Person-years 164,548 61,761 65,651 4,337 826
All deaths, n 12,315 5,459 6,662 603 154
Mortality rate, per 100 person-years 7.48 8.84 10.15 13.90 18.64
HR, unadjusted 1 0.99 (0.96–1.02) 1.06 (1.03–1.09) 1.54 (1.42–1.68) 2.50 (2.14–2.93)
HR, model 1 1 1.17 (1.13–1.21) 1.36 (1.32–1.40) 1.96 (1.81–2.13) 2.74 (2.33–3.21)
HR, model 2 1 0.99 (0.96–1.02) 1.07 (1.04–1.10) 1.45 (1.34–1.58) 2.29 (1.95–2.68)
HR, model 2, continuousa
Vascular deaths, n 1,060 506 708 100 32
HR, unadjusted 1 1.03 (0.92–1.14) 1.25 (1.13–1.37) 2.78 (2.26–3.41) 5.65 (3.97–8.03)
HR, model 1 1 1.26 (1.13–1.40) 1.66 (1.51–1.83) 3.68 (3.00–4.52) 6.31 (4.44–8.97)
HR, model 2 1 1.04 (0.93–1.15) 1.27 (1.15–1.40) 2.61 (2.12–3.20) 4.89 (3.44–6.95)
HR, model 2, continuousb
Non-vascular deaths, n 11,255 4,953 5,954 503 122
HR, unadjusted 1 0.98 (0.95–1.02) 1.04 (1.01–1.08) 1.42 (1.30–1.55) 2.18 (1.83–2.61)
HR, model 1 1 1.16 (1.12–1.20) 1.33 (1.29–1.37) 1.79 (1.64–1.96) 2.38 (1.99–2.85)
HR, model 2 1 0.98 (0.95–1.02) 1.05 (1.02–1.08) 1.34 (1.22–1.46) 2.01 (1.68–2.40)
HR, model 2, continuousc
Hazard ratio (95% CI). Model 1 adjusts for age, age-squared, and sex. Model 2 additionally adjusts for SIMD quintile, comorbidity (Charlson Index), COPD, and medical
speciality.
Results shown for glucose categorised and modelled as a polynomial.
aGlucose 1.16 (1.07–1.25). Glucose-squared 0.42 (0.36–0.48) and glucose cubed 1.35 (1.29–1.41).
bGlucose 1.24 (0.93–1.66). Glucose-squared 0.41 (0.27–0.63) and glucose cubed 1.40 (1.25–1.58).
cGlucose 1.15 (1.05–1.24). Glucose-squared 0.43 (0.37–0.50) and glucose cubed 1.33 (1.27–1.39).
doi:10.1371/journal.pmed.1001708.t006
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fying diabetes, such as population-based screening and opportu-
nistic testing. One reason why opportunistic testing for type 2
diabetes in the hospital setting is attractive is the higher proportion
of people from socio-economically deprived areas than in the
general population, a group known to be hard to reach through
screening programmes [45].
We found a lower risk of diabetes for a given glucose level in
people aged over 80 years. Potential mechanisms include a healthy
survivor effect, differences in glucose homeostasis, and a higher
prevalence of transient causes of increased glucose in this age
group such as increased use of corticosteroids and beta-agonists as
a result of the higher prevalence of COPD in older people [46].
Given the high mortality rate in those aged over 80 years following
hospital admission, however, many older patients with diabetes
may have died without receiving a diagnosis.
We had originally intended to examine the risk of type 2 diabetes
in patients aged 40 and older as type 2 diabetes is rare in patients
below this age. At the review stage, however, it was noted that our
cohort presents an opportunity to examine associations among
younger patients, in whom the risk of type 2 diabetes is increasing.
Figure 7. 3-year risk of type 2 diabetes and competing risks. Estimates of 3-year risk of type 2 diabetes in women aged 60 obtained by
multiplying the risk in women aged 60 with a glucose of 5 mmol/L (1.0%, obtained from the logistic regression model in Table 4) by the csHR and the
sdHR, respectively.
doi:10.1371/journal.pmed.1001708.g007
Table 7. Diabetes according to admission glucose from competing risks analysis.
Patient Characteristics/Glucose (mmol/l) ,6.1 6.1–6.9 7.0–11.0 11.1–14.9 $15
N 46,499 18,185 20,030 1,480 318
Person-years 164,548 61,761 65,651 4,337 826
Diabetes events 768 514 1,150 241 51
csHR 1 1.80; 95% CI
(1.61–2.01)
3.89; 95% CI
(3.55–4.26)
14.08; 95% CI
(12.18–16.28)
16.68; 95% CI
(12.56–22.15)
sdHR 1 1.82; 95% CI
(1.63–2.04)
3.88; 95% CI
(3.54–4.26)
12.02; 95% CI
(10.36–13.96)
11.55; 95% CI
(8.56–15.60)
csHR, continuousa
sdHR, continuousb
csHR (95% CI) derived from Cox regression model. sdHR (95% CI) derived from Fine and Gray regression model. All models adjust for age, age-squared, and sex. Results
shown for glucose categorised and modelled as a polynomial.
aGlucose 0.15 (0.11–0.19): Glucose-squared 18.33 (12.05–27.87): and glucose cubed 0.58 (0.52–0.65).
bGlucose 0.15 (0.11–0.20): Glucose-squared 22.74 (14.58–35.45): and glucose cubed 0.53 (0.47–0.60).
doi:10.1371/journal.pmed.1001708.t007
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We report the findings for younger patients separately and exclude
them from our risk calculator for a number of reasons: this analysis
was exploratory rather than pre-specified, patients aged less than 40
are not normally offered screening for type 2 diabetes [32,33], the
overall proportion with admission glucose levels above the WHO
cut-off for random glucose (11.1 mmol/l) was only around half that
of patients aged 40 and older (1% versus 2%), and the subsequent
risk of type 2 diabetes among those with a glucose of 11.1 mmol/l
was lower (7.8% versus 9.9%) than for older patients.
Moreover, since screening is not routinely offered in people
aged less than 40 years old [32,33], and as clinicians may be less
likely to diagnose type 2 diabetes as a result of its comparative
rarity in this group, there may be a stronger case for routinely
offering follow-up testing to patients with glucose at or above
11.1 mmol/l aged 30–39, compared to older patients, as the risk
of delayed diagnosis may be higher.
Different patterns of mortality did not appear to be responsible
for the weaker association between admission glucose and risk of
type 2 diabetes we observed among patients admitted to ICU.
Stress hyperglycaemia, first described by Claude Bernard in 1878,
occurs when an acute stressor such as sepsis and other acute illness
causes increased release of glucagon, cortisol, catecholamines,
growth hormone, and pro-inflammatory cytokines that promote
hepatic gluconeogenesis, glycogenolysis, inhibition of peripheral
glucose uptake, and inhibition of insulin release [11,12]. We
suspect that for many hospitalised patients, chronically reduced
beta-cell function acts in combination with these mechanisms to
cause elevated glucose. Among patients acutely unwell enough to
require subsequent admission to ICU, however, there may more
often be a sufficiently large counter-regulatory response to produce
stress hyperglycaemia in the presence of preserved pancreatic
reserve. If so, this could explain the weaker association between
admission glucose and subsequent diabetes in this group of
patients. Nonetheless, fewer than 2,000 patients in our cohort were
admitted to ICU, and there were only 37 events in this group, so
this observation should be treated very cautiously.
Limitations
One limitation of our study is that not all patients had admission
glucose recorded. However, this is unlikely to have biased our
estimates as the proportion with glucose measurements was high,
the risk of diabetes was similar for patients who did and did not
have glucose measured, and because similar results were obtained
among sub-groups in whom different percentages had admission
glucose measured, such as patients admitted to surgical compared
to medical specialties (55% versus 80%).
Table 8. Diabetes according to age, sex, and admission glucose from time to event analyses.
Variable in Model csHR sdHR
Age, per ten years 6.92 (5.15–9.29) 9.17 (6.86–12.26)
Age, per ten years, squared 0.85 (0.83–0.87) 0.83 (0.81–0.85)
Male 0.79 (0.73–0.86) 0.83 (0.77–0.90)
Glucose, mmol/l 0.15 (0.11–0.19) 0.15 (0.11–0.20)
Glucose, mmol/l, squared 18.33 (12.05–27.87) 22.74 (14.58–35.45)
Glucose, mmol/l, cubed 0.58 (0.52–0.65) 0.53 (0.47–0.60)
csHR (95% CI) derived from Cox regression model. sdHR (95% CI) derived from Fine and Gray regression model. Estimates are presented for all variables included in the
models.
doi:10.1371/journal.pmed.1001708.t008
Table 9. 3-year risk of type 2 diabetes by glucose, age, sex, and Scottish Index of Multiple Deprivation (SIMD) score: coefficients
and odds ratios from logistic regression models for patients aged 30–39.
Variable in Model Model 1 Model 2
b OR (95% CI) b OR (95% CI)
Intercept 211.843 211.338
Age, per ten year 0.085 1.09 (1.00–1.18) 0.087 1.09 (1.01–1.18)
Women 20.145 0.86 (0.55–1.35) 20.118 0.89 (0.57–1.39)
Glucose 23.078 0.05 (0.01–0.17) 22.839 0.06 (0.02–0.22)
Glucose squared 4.164 64.30 (7.83–528) 3.727 41.55 (4.88–354.11)
Glucose cubed 20.738 0.48 (0.27–0.83) 20.616 0.54 (0.31–0.95)
SIMD Quintile 1 (most deprived) — — 20.095 0.91 (0.53–1.56)
SIMD Quintile 2 — — 20.525 0.59 (0.30–1.18)
SIMD Quintile 3 — — 21.134 0.32 (0.12–0.83)
SIMD Quintile 4 — — 21.029 0.36 (0.15–0.83)
SIMD Quintile 5 (least deprived) — — 0.087 1.09 (1.01–1.18)
The natural logarithm of glucose in mmol/l was used for all models.
doi:10.1371/journal.pmed.1001708.t009
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Figure 8. 3-year risk and 5-year risk of type 2 diabetes by admission glucose among patients with 5 or more years of follow-up. The
solid lines represent the predicted risk with ribbons indicating the 95% CIs obtained from a logistic regression model of each outcome on glucose,
glucose-squared, and glucose-cubed, adjusting for age and sex.
doi:10.1371/journal.pmed.1001708.g008
Stress Hyperglycaemia in Hospitalised Patients and Risk of Diabetes
PLOS Medicine | www.plosmedicine.org 15 August 2014 | Volume 11 | Issue 8 | e1001708
The identification of incident diabetes we used was robust as all
clinical care for diabetes in Scotland is delivered using the SCI-DC
register from which we obtained our diagnoses. Nonetheless, our
definition of type 2 diabetes relied on clinical diagnosis, so people
with undiagnosed diabetes were not identified. The proportion of
people with diabetes who are undiagnosed may also differ
according to age, sex, or socio-economic status, which may, for
example, have attenuated the strength of the association between
socio-economic status and risk of type 2 diabetes. However, we
had 3 and 5 years of follow-up in the main and sensitivity analyses,
respectively, and would expect that the majority of patients with
incipient or undiagnosed diabetes during a hospitalisation would
be diagnosed within this timescale.
As we did not have serial blood glucose measurements for the
period between the date of discharge from hospital and the date of
diagnosis with type 2 diabetes, we are unable to state what
proportion of patients with high admission glucose who were later
diagnosed with type 2 diabetes had previously undetected type 2
diabetes, and what proportion experienced a temporary return to
normoglycaemia, in whom the high admission glucose could be
defined as isolated stress hyperglycaemia.
We did not have measures of body mass index (BMI), which
may have improved the discrimination of our model. Future
studies, perhaps including primary care data, in which BMI may have
been recorded, are needed. In a previous study in patients with stress
hyperglycaemia, however, BMI was not associated with risk of type 2
diabetes on 6-week follow-up oral glucose tolerance testing [27].
We are unable to comment on how these risks may differ by
ethnicity as recording of ethnicity in hospital data for Scotland for
the time period of the study was poor. Moreover, our risk
calculator has not been validated in non-white populations or
populations outside of Scotland.
The date of the end of follow-up was December 2011 as no
more recent research extract from SCI-DC that could be linked to
other databases was available at the time of publication. In the
intervening period there has been no substantial change in the
incidence of type 2 diabetes [42], clinical practice guidelines, or, to
our knowledge as practising clinicians working in diabetes,
cardiology, intensive care, and general medicine, in relevant
clinical practice.
Finally, a weakness of our study is that we were unable to state
whether glucose was measured on a fasting or non-fasting sample.
Similarly, as the WHO only approved HbA1c for identifying type
2 diabetes as an alternative to standard glucose measures, in 2011
[32], and this use is still not widespread in Scotland, we were
unable to assess the usefulness of HbA1c for diagnosing diabetes in
acutely ill populations. Our results are of relevance to clinical
practice however, as clinicians discharging patients from hospital,
and those responsible for after-care, are frequently required to
make decisions without having this information available.
Conclusion
The 3-year risk of type 2 diabetes was ,1% for patients with a
glucose of#5 mmol/l and increased linearly to approximately 15%
at 15 mmol/l, above which there was no further increase in risk.
The 3-year risks at the WHO diagnostic cut-points for fasting
(7 mmol/l) and random (11.1 mmol/l) glucose [34] were 3% and
10%, respectively. One in four and one in 40 patients had a glucose
level above these respective cut-points. Mortality was also 1.5-fold
higher in patients with glucose levels of 11.1 to 15 mmol/l
compared to those with glucose levels,6.1 mmol/l. These findings
can be used to inform individual patients of their long-term risk of
type 2 diabetes and to offer lifestyle advice as appropriate.
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Editors’ Summary
Background. Insulin—a hormone released by the pancreas
after meals—controls blood glucose (sugar) levels in healthy
individuals. However, many patients admitted to hospital
because of an acute illness have hyperglycemia, an abnor-
mally high blood glucose level. In this setting, hyperglycemia
can be caused by the drugs that patients are taking for
existing conditions or may be stress hyperglycemia, a
reversible condition in which hormonal changes induced
by acute illness stimulate glucose production by the liver.
However, hyperglycemia detected during an acute illness
may also indicate underlying or incipient type 2 diabetes, a
common condition in which blood glucose control fails. Type
2 diabetes can initially be controlled by diet, exercise, and
antidiabetic drugs but many patients eventually need insulin
injections to control their blood sugar level. Long-term
complications of type 2 diabetes, which include an increased
risk of heart attacks and stroke, reduce the life expectancy of
people with diabetes by about 10 years compared to people
without diabetes
Why Was This Study Done? Prompt diagnosis of type 2
diabetes can minimize its long-term complications, so
experts have designed several scoring systems based on
lifestyle and other characteristics that allow primary care
clinicians to identify the patients who should be tested for
diabetes because they are at high risk of developing the
condition. Unfortunately, these scoring systems cannot be
used to interpret a high blood glucose result obtained
during an acute illness so clinicians cannot currently advise
their patients on the clinical significance of this type of
abnormal glucose reading or make an informed decision
about whether follow-up testing is needed. In this retro-
spective cohort study, the researchers investigate the
association between blood glucose levels measured during
emergency hospital admissions in Scotland and the risk of
developing type 2 diabetes by linking together national
databases of hospital admissions, laboratory test results, and
people with diabetes. A retrospective cohort study examines
the medical histories of a group of patients.
What Did the Researchers Do and Find? The researchers
used the databases to identify more than 100,000 patients
aged 30 years or older who were admitted to a hospital for
an acute illness between 2004 and 2008 in Scotland, to
obtain information on blood glucose levels on admission for
nearly three-quarters of these patients, and to identify which
patients subsequently developed diabetes. They then used
statistical models to estimate the patients’ risk of developing
type 2 diabetes during the 3 years following hospital
discharge. Among patients aged 40 years or older, the
overall 3-year risk of developing diabetes was 2.3%. The risk
of developing diabetes increased linearly with increasing
blood glucose level at admission. Specifically, the 3-year risks
at blood glucose levels of 7 mmol/l and 11.1 mmol/l were
2.6% and 9.9%, respectively; because glucose levels fluctuate
according to when an individual last ate, fasting blood
glucose levels of 7 mmol/l and non-fasting blood glucose
levels of 11.1 mmol/l are used as thresholds for the diagnosis
of diabetes. The diabetes risk associated with blood glucose
levels on admission among 30–39-year-old patients followed
a similar pattern but was less marked. Finally, high glucose
levels on admission were associated with increased mortal-
ity.
What Do These Findings Mean? These findings indicate
that blood glucose measured during an emergency hospital
admission predicts the subsequent risk of type 2 diabetes
among patients aged 40 years or older (the analysis specified
in the researchers’ original protocol). Importantly, however,
they also suggest that a high blood glucose reading in these
circumstances usually indicates stress hyperglycemia rather
than type 2 diabetes. The accuracy and generalizability of
these findings may be limited by the lack of data on ethnicity
or body mass index (a measure of obesity), both of which
affect diabetes risk, and by other aspects of the study design.
Nevertheless, given their findings, the researchers recom-
mend that any patient with a blood glucose level above
11.1 mmol/l on hospital admission for an acute illness (one
in 40 patients in this study) should be offered follow-up
testing. In addition, the researchers constructed a risk
calculator using their findings that should help clinicians to
inform their patients about their long-term risk of diabetes
following hyperglycemia during an acute hospital admission
and to target lifestyle advice to those patients at the highest
risk of type 2 diabetes.
Additional Information. Please access these websites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001708.
N The US National Diabetes Information Clearinghouse
provides information about diabetes and about diabetes
prevention (in English and Spanish)
N The UK National Health Service Choices website provides
information about type 2 diabetes and about living with
diabetes; it also provides people’s stories about diabetes
N The charity Diabetes UK provides information about
diabetes in several languages, including information on
healthy lifestyles for people with diabetes
N Wikipedia has a page on stress hyperglycemia (note that
Wikipedia is a free online encyclopedia that anyone can
edit; available in several languages)
N More information about stress hyperglycemia is available
in Diapedia, a living textbook of diabetes produced by the
European Association for the Study of Diabetes
N GUARD (Glucose on Unselected Admissions and Risk of
Diabetes), a risk calculator that allows clinicians to estimate
a patient’s 3-year risk of diabetes following hyperglycemia
at hospital admission for an acute illness, is available online
N The UK-based non-profit organization Healthtalkonline has
interviews with people about their experiences of diabetes
N MedlinePlus provides links to further resources and advice
about diabetes and diabetes prevention (in English and
Spanish)
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